Results of Operations and Financial Condition. On August 6, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three and six month period ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, shall be dee…

The filing describes an amendment to the equity incentive plan, not a management change.

Results of Operations and Financial Condition. On May 7, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three-month period ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, shall be deemed to be…

Director — John A. DeFord, Ph.D.: Dr. DeFord resigned from the Board of Directors.

Results of Operations and Financial Condition. On February 24, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three and twelve-month periods ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, s…

Results of Operations and Financial Condition. On January 7, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting the Company’s preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2025. The press release also included preliminary guidance for certain financial measures for the fiscal year ending December 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. I…

Results of Operations and Financial Condition. On November 6, 2025, we issued a press release reporting, among other things, our sales and operating results for the three and nine month period ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed”…

Results of Operations and Financial Condition. On August 7, 2025, we issued a press release reporting, among other things, our sales and operating results for the three and six month period ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with th…

CEO — Daniel T. Scavilla: The CEO resigned but was immediately succeeded by an internal promotion (COO/CFO to CEO), indicating an orderly succession rather than a sudden loss of leadership.

Results of Operations and Financial Condition. On July 21, 2025, Globus Medical, Inc. (the “Company”) issued a press release including preliminary sales results for the second quarter ending June 30, 2025 and other information described in

The filing discloses the approval of an amendment to an equity incentive plan, which is a compensatory arrangement rather than a change in management personnel.

Other Events. On May 15, 2025, Globus Medical, Inc. issued a news release announcing a program to repurchase $500 million of the Company’s Class A common stock. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Results of Operations and Financial Condition. On May 8, 2025, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securiti…

Completion of Acquisition or Disposition of Assets. On April 3, 2025 (the “Closing Date”), Globus Medical, Inc., a Delaware corporation (“Globus”), completed the previously announced merger of Palmer Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Globus (“Merger Sub”), with and into Nevro Corp., a Delaware corporation (“Nevro”) (the “Merger”), with Nevro surviving the Merger as a wholly owned subsidiary of Globus. The Merger was effectuated pursuant to the Ag…

Results of Operations and Financial Condition. On February 20, 2025, we issued a press release reporting, among other things, our sales and operating results for the three- and twelve-month periods ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “fi…

Entry into a Material Definitive Agreement. On February 6, 2025, Globus Medical, Inc., a Delaware corporation (“Globus Medical”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Nevro Corp., a Delaware corporation (“Nevro”), and Palmer Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Globus Medical (“Merger Sub”). The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein,…

Results of Operations and Financial Condition. On January 8, 2025, we issued a press release reporting our preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2024. The press release also included preliminary guidance for certain financial measures for the 2025 fiscal year. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02,…

Results of Operations and Financial Condition. On November 5, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the…

Results of Operations and Financial Condition. On August 6, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securi…

The filing discloses the approval of an amendment to an equity incentive plan, which is a compensatory arrangement rather than a change in management personnel.

Results of Operations and Financial Condition. On May 7, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securiti…